What is the clinical evidence from this study?

Study design: Observational. Population: Advanced ischemic cardiomyopathy. Intervention: Coronary artery bypass grafting (CABG). Primary outcome: Safety, angina, congestive heart failure, ejection fraction, and longevity.

What question did this study set out to answer?

This research aims to evaluate the safety and effectiveness of CABG in patients with advanced ischemic cardiomyopathy.

February 1, 1995Cardiology ClinicsOpen Access

Cabg in Advanced Left Ventricular Dysfunction

View Full Paper

Ask AI

Bookmark

Key result

CABG in patients with advanced ischemic cardiomyopathy safely improves angina, heart failure, and ejection fraction, suggesting it as a viable alternative to heart transplantation.

Why the study?

Does CABG improve symptoms and survival in patients with advanced ischemic cardiomyopathy?

Population

Patients with advanced ischemic cardiomyopathy

Design

Case_series

Authors

JEJohn A. ElefteriadesYale New Haven Hospital IKIrving L. KronCardiac Surgery

Discussion

Member takes

Implication

Should not change practice yet; leaves open CABG's comparative role versus transplantation in randomized trials.

Key Points

This research aims to evaluate the safety and effectiveness of CABG in patients with advanced ischemic cardiomyopathy.
Conducted a concurrent clinical series at Yale University and the University of Virginia.
Evaluated outcomes including ejection fraction, angina, and congestive heart failure symptoms.
Assessed the safety of the internal mammary conduit in the patient population.
CABG improved ejection fraction significantly, with a noted increase in heart function.
Patients experienced improvements in angina and congestive heart failure states.
Good long-term longevity was achieved, indicating CABG as a potential alternative to heart transplantation.

Study Design

Type

Observational

Multicenter

Yes

Structured PICO

Does CABG improve symptoms and survival in patients with advanced ischemic cardiomyopathy?

Population

Patients with advanced ischemic cardiomyopathy

Intervention

Coronary artery bypass grafting (CABG), including use of the internal mammary conduit

CABG is suggested as a safe and effective alternative to heart transplantation in patients with advanced ischemic cardiomyopathy, improving symptoms, ejection fraction, and longevity.

Cite This Study

Elefteriades et al. (1995) conducted an observational in Advanced ischemic cardiomyopathy. Coronary artery bypass grafting (CABG) was evaluated on Safety, angina, congestive heart failure, ejection fraction, and longevity. CABG in patients with advanced ischemic cardiomyopathy safely improves angina, heart failure, and ejection fraction, suggesting it as a viable alternative to heart transplantation.

synapsesocial.com/papers/6a0d3db336162e2f4b09a89b https://doi.org/10.1016/s0733-8651(18)30060-2

Topics

HFrEF treatment Heart transplantation Heart failure

View Full Paper

Ask AI

Bookmark

Cabg in Advanced Left Ventricular Dysfunction

Discussion

Member takes

Implication

Key Points

Study Design

Structured PICO

Cite This Study

Topics

Cabg in Advanced Left Ventricular Dysfunction

Discussion

Member takes

Implication

Key Points

Study Design

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider